Edwards Lifesciences Corp 4
4 · Edwards Lifesciences Corp · Filed Apr 27, 2012
Insider Transaction Report
Form 4
REINDL ROBERT C
CVP, H.R. and Communications
Transactions
- Sale
Common Stock
2012-04-25$80.96/sh−17,701$1,433,073→ 5,776 total - Sale
Common Stock
2012-04-25$82.29/sh−6,799$559,490→ 23,477 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2012-04-25−24,500→ 0 totalExercise: $22.95From: 2006-05-12Exp: 2012-05-11→ Common Stock (24,500 underlying) - Exercise/Conversion
Common Stock
2012-04-25$22.95/sh+24,500$562,275→ 30,276 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2012.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $82.00 to $82.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $80.00 to $81.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.